Silex Systems Stock price
Compare with Peer Group
Is Silex Systems a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Silex Systems Stock Analysis
Analyst Opinions
7 Analysts have issued a Silex Systems forecast:
Analyst Opinions
7 Analysts have issued a Silex Systems forecast:
Don't miss a Thing! We will send you all news about Silex Systems directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Silex Systems Ltd. engages in the development and commercialization of laser uranium enrichment technology. The company is headquartered in Sydney, New South Wales. The firm is focused on the commercialization of its Separation of Isotopes by Laser EXcitation (SILEX) laser enrichment technology for application to uranium production and enrichment (nuclear power), silicon enrichment (silicon quantum computing) and medical isotope enrichment (new cancer therapies). Its segments include Silex Systems, Translucent and Silex USA. Silex Systems is based in New South Wales and Translucent and Silex USA are based in North Carolina. The SILEX technology has been under development for uranium enrichment jointly with exclusive licensee Global Laser Enrichment LLC. The company is also focused on the development of additional commercial applications of the SILEX technology, including the production of Zero-Spin Silicon for the emerging technology of silicon-based quantum computing. The company has an interest in a semiconductor technology known as cREO through its ownership of subsidiary Translucent Inc.
| Head office | Australia |
| CEO | Dr. Goldsworthy |
| Employees | 41 |
| Website | www.silex.com.au |


